Orenitram (United Therapeutics Corp.)


Welcome to the PulseAid listing for the Orenitram drug offered from United Therapeutics Corp.. This Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: United Therapeutics Corp.
NON-PROPRIETARY NAME: treprostinil
SUBSTANCE NAME: TREPROSTINIL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET, EXTENDED RELEASE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-12-20
END MARKETING DATE: 0000-00-00


Orenitram HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOrenitram from United Therapeutics Corp.
LABELER NAME: United Therapeutics Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.125(mg/1)
START MARKETING DATE: 2013-12-20
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66302-300_3d03a0e3-a4b7-4367-95c5-566ccf6f1da2
PRODUCT NDC: 66302-300
APPLICATION NUMBER: NDA203496

Other TREPROSTINIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalOrenitram
United Therapeutics Corp.TYVASO
United Therapeutics CorporationRemodulin